Consensus DocuSign, Inc.

Equities

DOCU

US2561631068

Real-time Estimate Cboe BZX 10:51:57 2024-06-10 am EDT 5-day change 1st Jan Change
51.58 USD -0.89% Intraday chart for DocuSign, Inc. -3.84% -13.56%

Evolution of the average Target Price on DocuSign, Inc.

Price target over the last 5 years

History of analyst recommendation changes

1c8b7ddf8661027925a1277b682d00fb.v-TYIZECDAE_ysuK2WURhtNlooWuPdFeF3-5tNmNqbU.4LyaSP1gekxvkvjD6TUj9KAOzd_Dbb4HWwjzxazL7_3Jle5Q9Ho0U1WvqA~b374e7442aa913c1b002019825da460d
Morgan Stanley Cuts Price Target on DocuSign to $62 From $65 on Slow Growth, Tight Guidance Range; Keeps Equalweight Rating MT
Piper Sandler Cuts Price Target on DocuSign to $60 From $65, Maintains Neutral Rating MT
Baird Adjusts Price Target on DocuSign to $55 From $65, Maintains Neutral Rating MT
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Friday; AMC Entertainment to Advance, DocuSign to Decline MT
Morgan Stanley Trims Price Target on DocuSign to $62 From $65, Keeps Equalweight Rating MT
RBC Cuts Price Target on DocuSign to $52 From $59, Says 'Skinny Beat Tempers Near-Term Expectations,' Keeps Sector Perform Rating MT
Docusign Insider Sold Shares Worth $415,847, According to a Recent SEC Filing MT
DocuSign Wants to Stay Public Despite Private Equity Takeover Rumors, CEO Says MT
Docusign Insider Sold Shares Worth $454,110, According to a Recent SEC Filing MT
UBS Upgrades DocuSign to Neutral From Sell, Adjusts Price Target to $62 From $48 MT
Docusign Insider Sold Shares Worth $900,000, According to a Recent SEC Filing MT
Docusign Insider Sold Shares Worth $640,080, According to a Recent SEC Filing MT
Docusign Insider Sold Shares Worth $456,147, According to a Recent SEC Filing MT
Morgan Stanley Lifts Price Target on DocuSign to $65 From $64, Keeps Equalweight Rating MT
Citigroup Adjusts DocuSign's Price Target to $93 From $90, Maintains Buy Rating MT
Baird Adjusts DocuSign's Price Target to $65 From $50, Maintains Neutral Rating MT
UBS Raises DocuSign Price Target to $48 From $44, Maintains Sell Rating MT
Wells Fargo Adjusts Price Target on DocuSign to $48 From $45, Maintains Underweight Rating MT
Piper Sandler Raises Price Target on DocuSign to $65 From $55, Maintains Neutral Rating MT
RBC Raises Price Target on DocuSign to $59 From $50 After 'Solid Quarter,' Says 'Margin Upside Offsets Muted Growth Outlook,' Keeps Sector Perform Rating MT
Wedbush Raises DocuSign's PT to $65 From $56 After Higher-Than-Expected Fiscal Q4 Results, Maintains Neutral Rating MT
Evercore ISI Adjusts DocuSign Price Target to $60 From $55, Maintains In Line Rating MT
HSBC Adjusts DocuSign Price Target to $52 From $44, Maintains Hold Rating MT
JPMorgan Adjusts DocuSign Price Target to $50 From $45, Maintains Underweight Rating MT
Delving Into the Disconnect Over the U.S. Economy; Mester Says No Need to Rush Fed Rate Cuts DJ
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
25
Last Close Price
52.05 USD
Average target price
62.63 USD
Spread / Average Target
+20.32%
High Price Target
86 USD
Spread / Highest target
+65.23%
Low Price Target
48 USD
Spread / Lowest Target
-7.78%

Consensus detail

Consensus revision (last 18 months)

Analysts covering DocuSign, Inc.

Morgan Stanley
Piper Sandler
Baird
RBC Capital Markets
UBS
Citigroup
Wells Fargo Securities
JPMorgan Chase
Wedbush
Evercore ISI
HSBC
BofA Securities
Daiwa Securities
MoffettNathanson Research
Morningstar
Jefferies & Co.
Wolfe Research
Argus
JMP Securities
William Blair & Co.
Oppenheimer
Needham & Co.
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
  1. Stock Market
  2. Equities
  3. DOCU Stock
  4. Consensus DocuSign, Inc.